PNAS letter

Sir(s)

I´d like to introduce the disclosure of

non-specific low back pain.

The disclosure would gain clinical studies done with the objective follow up and outcome
much more advanced than before. Working with a bedside technique diagnosis and
treatment would be obtained simultaneously without costly and hazardous radiation. Earlier
Cochrane reviews have no studies on diagnosis setting for non-specific low back pain, only
treatments. Cibulka was once quite close to disclose the matter of mechanical low back pain,
but he could not repeat his results.

I apply to you helping to spread the knowledge of non-specific low back pain.
There is a preparation for publication of the basic technique, but before its publication I
want to have a clinical study running.
The non-specific low back pain was revieled by me as a specific type at a meeting in
Katmandu, Nepal 2010 under the headline of pain. The decade of 2000-2010 was proclaimed
internationally as the bone, joint and spine decade. That stimulated us to solve this pain
problem. It is the main part 80-85% of the total back pain problem. Later in 2011 NIH,
national Institute of Health and IOM, institute of medicine, had a call on ”Relieving Pain in
America”. Please, excuse my copying the exert in the adduct below.

I want clinical studies started about ”non-specific low back pain” and can support those
interested in the spirit and recommendations of the lines suggested by the Cochrane back and
neck group.

Before starting a treatment, there should be a diagnosis according to elementary textbooks in

medicine. This missed sentence is one of the explanation of the draw back of development in
this painsticking affair, costing US about 100-150 billion a year besides the cost, pain and
suffering of inhabitants not involved, those debiliated and under eigteen and over sixtyfive of
age..

Several universities have via their vice chancellors obtained an attempt from me to start a
coworking for the subject of relieving and revealing non specific or mechanical low back pain
and ….I am still waiting for an answer.

The description of the coupled system to relieve low back pain might have been read in patent
applications done in Google for US as well as for Australia under my companys name Steson
Praktik AB. I work as a retired GP.
My background is as a biochemist working with coupled enzyme systems revealing the
reduction and activation of bound thiamine and other mixed disulfides. Heavy metals bound
to proteins would also be detoxified by thioltransferase.
That enzyme as it has turned out is a key factor in RNA DNA formation, mitochondrion and
tubulin regulation. The polymerization of tubulin was early shown in cooperation with prof
Rabin and Ii, Virginia.
Born in 1941 and having no connections with Swedish universities, I asked them all with the
academic profession of orthopedics if they had similar objects to study further on, no was the
answer. I have taken part in clinical studies before as a unit in GP for ex. CAPPP, LIFE and
ASCOT. I have now no capacity for starting clinical studies as a private person and offer a
very fast way for the simultaneous analysis and treatment of the up to now non-specific or
mechanical low back pain for clinics to get results published.

Should I write an open letter for invitation to these studies in PNAS or in another way as to
apply to IOM?
Yours
StellanEriksson,Primusg.76, SE112 67 Stockholm, Sweden,
stellanaxel@gmail.com

Sirs
Sirs,

It is appreciated that US is taken a great concern in avoiding the common missuse of opioids.
Furthermore physicians by prescribing first NSAID and then opioids are getting lazier and don
´t bother to find the source of pain as they use symptom diagnosis and prescribe pain killers,
enough for the patient and pressured time scale.
Non-specific or mechanical low back pain is one of the most frequent diseases and may
cause many referred symtoms costing US over 150 billion dollars a year. By measuring in two
body planes you easily and fast get both the diagnosis and treatment in one seance first
described in a congress in Katmandu 2010. Earlier there has been no explaineable cause of
low back pain.
However I have in vain tried to interest vice chancellors at the most well known universities.

In 1970th thanks to EPA toxicological studies I managed to stop the diagnosticum Gastrotest,
a diamino azo compound applied to people already having a four fold higher cancer risk.
Earlier I worked as a biochemist with obligatorily coupled enzyme systems. With cooperation
with late Rebun and Ii, Virginia we first showed polymerization of tubulin via the enzyme
thioltransferase in an abstract 1970th.

This unnecessary low back pain will turn many victims into opioid drug addiction and by
NSAID prescription cause heart and kidney diseases.

I will generously help to spread information on how to diagnose and treat low back pain.

Yours

Stellan Eriksson
Primusgatsn 76
SE 112 67 Stockholm
Sweden

Tel 0046 702164372

e-mail: stellanaxel@gmail.com